Portfolio Synergy PhosphoSolutions now operates within the Antibodies Inc. family, enabling cross selling into Bioporto affinity-purified antibodies, recombinant guinea pig and chimeric antibody products, and other portfolio capabilities to meet broader customer needs.

Validation Upsell The focus on testing against endogenous proteins and rigorous validation creates an opportunity to upsell validation and assay development packages, including customization and bundled testing to accelerate project timelines for customers.

Expanded Species Lines Access to Guinea Pig Chimeric Antibodies and other new lines supports customers needing diverse species and recombinant formats, enabling targeted outreach to neuroscience and signaling pathway researchers.

Supply Consistency A serum pooling approach that reduces lot-to-lot variability positions PhosphoSolutions as a reliable supplier for large studies, enabling volume commitments or preferred supplier arrangements with labs managing reproducibility concerns.

Strategic Growth The ongoing integration and multiple product launches under Antibodies Inc, along with acquisitions like Biosensis, signal a growing ecosystem for partnerships, co-marketing, and expanded distribution to academic and biotech customers.